These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 18205228

  • 1. Genotype dependence of peptide-based immunoassays for the detection of HCV core antibodies.
    Muerhoff AS, Gutierrez R, Kyrk C, Leary T, Schlauder G, Dawson G, Desai SM.
    J Med Virol; 2008 Mar; 80(3):411-8. PubMed ID: 18205228
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Evaluation of core and NS4B synthetic peptide-based immunoassays for the detection of hepatitis C virus antibodies in clinical samples from Cameroon, Central Africa.
    Njouom R, Nerrienet E, Budkowska A, Maillard P, Rousset D, Kalinina O, Mavromara P, HCV Collaborative Team of the International Pasteur Network.
    J Clin Virol; 2010 Sep; 49(1):61-4. PubMed ID: 20621554
    [Abstract] [Full Text] [Related]

  • 4. Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection.
    Bain C, Parroche P, Lavergne JP, Duverger B, Vieux C, Dubois V, Komurian-Pradel F, Trépo C, Gebuhrer L, Paranhos-Baccala G, Penin F, Inchauspé G.
    J Virol; 2004 Oct; 78(19):10460-9. PubMed ID: 15367612
    [Abstract] [Full Text] [Related]

  • 5. Effects of interferon treatment on the antiviral T-cell response in hepatitis C virus genotype 1b- and genotype 2c-infected patients.
    Missale G, Cariani E, Lamonaca V, Ravaggi A, Rossini A, Bertoni R, Houghton M, Matsuura Y, Miyamura T, Fiaccadori F, Ferrari C.
    Hepatology; 1997 Sep; 26(3):792-7. PubMed ID: 9303515
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antigenic relevance of F protein in chronic hepatitis C virus infection.
    Komurian-Pradel F, Rajoharison A, Berland JL, Khouri V, Perret M, Van Roosmalen M, Pol S, Negro F, Paranhos-Baccalà G.
    Hepatology; 2004 Oct; 40(4):900-9. PubMed ID: 15382175
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
    Chen Y, Xiong X, Liu X, Li J, Wen Y, Chen Y, Dai Q, Cao Z, Yu W.
    Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
    [Abstract] [Full Text] [Related]

  • 11. Use of overlapping synthetic peptides to characterize samples from blood donors with indeterminate results to hepatitis C virus core antigen.
    León P, López JA, Elola C, Lee SR, Calmann M, Echevarría JM.
    Vox Sang; 1998 Feb; 75(1):32-6. PubMed ID: 9745151
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Artificial NS4 mosaic antigen of hepatitis C virus.
    Chang JC, Ruedinger B, Cong M, Lambert S, Lopareva E, Purdy M, Holloway BP, Jue DL, Ofenloch B, Fields HA, Khudyakov YE.
    J Med Virol; 1999 Dec; 59(4):437-50. PubMed ID: 10534724
    [Abstract] [Full Text] [Related]

  • 14. A human monoclonal antibody specific for the N terminus of the hepatitis C virus nucleocapsid protein.
    Cerino A, Boender P, La Monica N, Rosa C, Habets W, Mondelli MU.
    J Immunol; 1993 Dec 15; 151(12):7005-15. PubMed ID: 7505020
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antibodies to a novel antigen in acute hepatitis C virus infections.
    Tobler LH, Stramer SL, Chien DY, Lin S, Arcangel P, Phelps BH, Cooper SL, Busch MP.
    Vox Sang; 2007 Jan 15; 92(1):1-7. PubMed ID: 17181584
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Characterisation of a panel of monoclonal antibodies raised against recombinant HCV core protein.
    Ferns RB, Tuke PW, Sweenie CH.
    J Med Virol; 1996 Nov 15; 50(3):221-9. PubMed ID: 8923286
    [Abstract] [Full Text] [Related]

  • 19. Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapy.
    Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Kuzuya T, Honda T, Hayashi K, Nakano I, Katano Y, Goto H.
    Clin Infect Dis; 2005 Mar 15; 40(6):e49-54. PubMed ID: 15736006
    [Abstract] [Full Text] [Related]

  • 20. Cross-reactivity and clinical impact of the antibody response to hepatitis C virus second envelope glycoprotein (E2).
    Hadlock KG, Gish R, Rowe J, Rajyaguru SS, Newsom M, Warford A, Foung SK.
    J Med Virol; 2001 Sep 15; 65(1):23-9. PubMed ID: 11505439
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.